ALC-0159

CAS No. 1849616-42-7

ALC-0159( —— )

Catalog No. M28735 CAS No. 1849616-42-7

ALC-0159 is a polyethylene glycol (PEG) lipid conjugate that could be used as a vaccine excipient.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 50 Get Quote
10MG 80 Get Quote
25MG 140 Get Quote
50MG 250 Get Quote
100MG 372 Get Quote
200MG 554 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ALC-0159
  • Note
    Research use only, not for human use.
  • Brief Description
    ALC-0159 is a polyethylene glycol (PEG) lipid conjugate that could be used as a vaccine excipient.
  • Description
    ALC-0159 is a polyethylene glycol (PEG) lipid conjugate that could be used as a vaccine excipient.(In Vitro):ALC-0159 promotes nanoparticle stabilization by a steric mechanism through its poly(ethylene glycol) (PEG) moiety.
  • In Vitro
    ALC-0159, which contributes to nanoparticle stabilization by a steric mechanism through its poly(ethylene glycol) (PEG) moiety.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    HIF-1α
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1849616-42-7
  • Formula Weight
    ——
  • Molecular Formula
    (C2H4O)nC31H63NO2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL
  • SMILES
    N.CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(=O)COCCOC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Moreno-Manzano et al (2010) FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status. J.Biol.Chem. 285 1333
molnova catalog
related products
  • Meglumine

    Meglumine is an amino sugar derived from sorbitol.

  • Benfluorex hydrochlo...

    Benfluorex is an anorectic and hypolipidemic agent that is structurally related to fenfluramine.

  • Acrivastine

    Acrivastine is a short-acting histamine 1 receptor antagonist.